Ryo Kawaura

6PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 05, 2026
Interstitial lung disease in patients with recurrent and metastatic head and neck cancer treated with immune checkpoint inhibitors and cetuximab and/or paclitaxel.

|Mar 02, 2026
Long-term follow-up of neoadjuvant chemotherapy in resectable human papillomavirus-associated oropharyngeal cancer.

Ryo Kawaura, Tomoya Yokota, Kunihiro Fushiki

|Sep 12, 2025
Prognosis After Discontinued Treatment due to Immune-Related Adverse Events in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma.

Hiromasa Ishihara, Yuki Asahi, Masashi Kuroki

|Aug 22, 2025
Targeting the cancer glycocalyx in salivary duct carcinoma: tumor-associated mucin 1 (Tn-MUC1) as a novel cell surface marker.

Masashi Kuroki, Ryo Kawaura, Hiroyuki Tomita

|May 29, 2025
Quantitative Assessment of Vestibular Function by Video Head Impulse Test and Vestibular-Evoked Myogenic Potential During Cisplatin-Based Chemoradiation.

Natsuki Takada, Hiroshi Okuda, Hirofumi Shibata

|Dec 17, 2024
Immune-Modified Glasgow Prognostic Score Predicts Therapeutic Effect of Pembrolizumab in Recurrent and Metastatic Head and Neck Cancer.

Natsuko Ueda, Masashi Kuroki, Hirofumi Shibata

Pageof 1

Frequent Collaborators

3 joint publications

Hiroshi Okuda

2 joint publications

Hirofumi Shibata

2 joint publications

Tomoya Yokota

2 joint publications

Yusuke Onozawa